Phillip A. Sharp, PhD
Institute Professor, MIT
Koch Institute, MIT

30 Years of Convergence

Eric Lander, PhD
President and Founding Director, Broad Institute of Harvard and MIT
Professor of Biology, Department of Biology, MIT
Koch Institute, MIT
Professor of Systems Biology, Harvard Medical School

Synthetic biology and next-generation diagnostics

James Collins, PhD
Termeer Professor of Medical Engineering and Science and Professor of Biological Engineering, MIT
Broad Institute of Harvard and MIT
Wyss Institute

Cancer Genome and the Cloud

Gad Getz, PhD
Director, Cancer Genome Computational Analysis Group, Broad Institute of Harvard and MIT

Targeting Aggressive Cancers Nanolayers at a Time: A Platform Approach to Engineered Nanomedicine

Paula T. Hammond, PhD
David H. Koch Professor in Engineering, MIT
Head of the Department of Chemical Engineering, MIT
Koch Institute, MIT

New chemical engineering approaches to convergence

Robert S. Langer, ScD
David H. Koch Institute Professor, MIT
Koch Institute, MIT

Understanding transcription and splicing heterogeneity in cancer progression

Daniel Larson, PhD
NIH Stadtman Investigator, Center for Cancer Research
Head, Systems Biology of Gene Expression, National Cancer Institute

Computational Models of Cancer

Franziska Michor, PhD
Professor of Computational Biology, Dana-Farber Cancer Institute
Harvard T.H. Chan School of Public Health

Spherical Nucleic Acids as a Powerful New Platform for Cancer Therapy

Chad A. Mirkin, PhD
Director, International Institute for Nanotechnology
George B. Rathmann Professor of Chemistry, Department of Chemistry, Northwestern University

Dissecting the tumor ecosystem with single cell genomics

Aviv Regev, PhD
Core Institute Member, Chair of the Faculty, Broad Institute of Harvard and MIT
Co-director of the Cell Circuits Program, Broad Institute of Harvard and MIT
Koch Institute, MIT

Illuminating biology at the nanoscale and systems scale using single-molecule and super-resolution imaging

Xiaowei Zhuang, PhD
David B. Arnold Professor of Science, Harvard University
Howard Hughes Medical Institute Investigator

Cori Bargmann, PhD
President of Science, Chan Zuckerberg Initiative

Marc N. Casper, MBA
President and CEO, Thermo Fisher Scientific

Victor Dzau, MD
President, National Academy of Medicine

Tyler Jacks, PhD
Director, Koch Institute, MIT
David H. Koch Professor of Biology, MIT

Nancy Simonian, MD
CEO, Syros Pharmaceuticals, Inc.

Elias Zerhouni, MD
President for Global Research and Development, Sanofi
Former Director, NIH

Moderated by:

Susan Hockfield, PhD
President Emerita, MIT
Professor of Neuroscience, MIT
Koch Institute, MIT